[go: up one dir, main page]

HK40082904A - Therapy for the treatment of cancer - Google Patents

Therapy for the treatment of cancer Download PDF

Info

Publication number
HK40082904A
HK40082904A HK62023071917.6A HK62023071917A HK40082904A HK 40082904 A HK40082904 A HK 40082904A HK 62023071917 A HK62023071917 A HK 62023071917A HK 40082904 A HK40082904 A HK 40082904A
Authority
HK
Hong Kong
Prior art keywords
cancer
therapy
treatment
Prior art date
Application number
HK62023071917.6A
Other languages
Chinese (zh)
Inventor
Bradley James SUMROW
Ross La Motte-Mohs
Jon Marc WIGGINTON
Ezio Bonvini
Paul A. Moore
Scott Koenig
Xiaoyu Zhang
Original Assignee
Macrogenics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrogenics, Inc. filed Critical Macrogenics, Inc.
Publication of HK40082904A publication Critical patent/HK40082904A/en

Links

HK62023071917.6A 2019-12-23 2020-12-18 Therapy for the treatment of cancer HK40082904A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US62/952,859 2019-12-23
US62/952,878 2019-12-23
US63/019,857 2020-05-04
US63/021,556 2020-05-07
US63/031,453 2020-05-28
US63/123,581 2020-12-10

Publications (1)

Publication Number Publication Date
HK40082904A true HK40082904A (en) 2023-06-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3849549A4 (en) Combination therapy for the treatment of triple-negative breast cancer
EP3781564A4 (en) Compounds for the treatment of cancer
ZA202206743B (en) Therapy for the treatment of cancer
EP4010081A4 (en) Combination therapy for treatment of cancer
EP3860610A4 (en) Combination therapy for the treatment of cancer
EP3897649A4 (en) Combination therapy of solid cancer
IL323370A (en) Indazolyl-isoxasole derivative for the treatment of cancer
IL284162A (en) Combination therapy for the treatment of cancer
EP3962524A4 (en) Cancer treatment
EP3856784A4 (en) Pharmaceutical combination for the treatment of cancer
HK40082904A (en) Therapy for the treatment of cancer
HK40080165A (en) Therapy for the treatment of cancer
HK40061708A (en) Combination therapy for the treatment of cancer
HK40060019A (en) Combination therapy for the treatment of cancer
HK40097873A (en) Combination therapy for the treatment of cancer
HK40097938A (en) Combination therapy for the treatment of cancer
HK40122434A (en) Pharmaceutical combination for the treatment of cancer
HK40114414A (en) Dr5-targeting multabodies for the treatment of cancer
HK40101281A (en) Combination therapies for the treatment of cancer
HK40094743A (en) Combinations for the treatment of cancer
HK40112300A (en) Methods for the treatment of cancer
HK40103380A (en) Combination therapies for the treatment of cancer
HK40103377A (en) Combination therapies for the treatment of cancer
HK40103172A (en) Combination therapies for the treatment of cancer
HK40080960A (en) Combination therapy for treating cancer